Communicate Your Unique Value Proposition for Successful Business Partnering
19 March 2024
Do you want to learn how to communicate your unique selling proposition? Ahead of BIO2024, join our WA Life Sciences Innovation Hub’s ‘Workshop with Profile Media: Communicating your unique value proposition’ to get ready for business partnering in 2024!
In this session, you’ll hear from ex-journalist and Profile Media founder Sue Papadoulis on how to put your best foot forward in partnering meetings and conferences.
As a journalist with a 20 plus-year career in the media, Sue understands the media industry. She has worked as a news editor, journalist, public relations executive and PR consultant for government and private enterprise. Sue is also the founder of the Good News Movement, a channel aimed at inspiring change in the way news is reported so there is more positivity.
In the workshop-based session, you will learn:
- How to identify your key messages for specific target audiences
- How to speak confidently about your idea or business
- How to tell the right story to convey authenticity and build connection
As this session will be workshop-based, you will leave with practical ways to implement your communication strategy at conferences. This workshop is open to those heading to BIO2024 and those companies about to engage in partnering conversations, particularly within a conference setting.
When: Wednesday 17 April, 2.30 pm – 4 pm AWST
Where: Harry Perkins Institute of Medical Research, Perth
Please note that this event has sold out! Please email Tracey Wilkinson to be placed on the waitlist.
About Profile Media
Profile Media is a trusted strategic communications partner for organisations seeking to build their reputation, grow their profile and broaden their credibility among audiences that matter.
Profile Media specialises in the health tech sector, generating national, state and local media coverage, as well as social media content for organisations including Linear Clinical Research, Argenica Therapeutics, Proteomics, Skin Genetics, Zelira , Emyria and Osteopore.